Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RELATION: Ranibizumab + Laser vs Laser Monotherapy in DME
NCT01131585Phase 3Terminated
- Sponsor
- Novartis
- Start
- Jun 2010
- Primary completion
- Jul 2011
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of ranibizumab in diabetic macular edema (DME), sponsored by Novartis. Started Jun 2010; status: terminated.
02
Drugs
ranibizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT01131585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01131585.